Can Inhibition of Enzyme Prevent Neovascularization Seen in Diabetic Retinopathy and Retinopathy of Prematurity?

January 15, 2011

Researchers at the Medical College of Georgia recently announced the results of a study showing that the inhibition or removal of an enzyme known as 12-lipoxygenase may prevent or treat ischemic retinopathy by stalling growth of unwanted vessels in the retina.

Lead researcher Dr. Mohamed Al-Shabrawey stated:

[I]f we can target or inhibit this enzyme’s pathway, we might be able to prevent or treat diseases of ischemic retinopathy.

Click here to read the full story.




Jump down to form below to submit your own comments

Comments are closed.